MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-30-0002353
Spica Laboratories Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹50.21 Cr
▼ 4% YoY
Net profit · FY 2025
₹3.66 Cr
Net margin 7.3%
EBITDA · FY 2025
₹6.92 Cr
EBITDA margin 13.8%
Authorised capital
₹8 Cr
Registered with MCA
Paid-up capital
₹5 Cr
Issued & subscribed
Satisfied charges
₹90 Lakh
No open charges
Company age
21 yrs
Est. 2005
Directors on board
4
As per MCA filings
About Spica Laboratories Private Limited
Data last updated:
Spica Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 February 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2005PTC045438. Its GSTIN is 36AAICS8206P1ZQ (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹5 Cr. It is led by directors including Nikhil Thota (Managing Director) and Giridhar Thota.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Krishe Sapphire 6th Floor 6B Survey No.88 Madhapur Village Serilingampalli Mandal, Hyderabad, Telangana, India – 500081.
As per the financials filed for FY 2025, the company reported a revenue of ₹50.21 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹3.66 Cr (net margin 7.3%) and EBITDA of ₹6.92 Cr (EBITDA margin 13.8%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 15% over five years.
As per MCA filings, the company has satisfied charges of ₹90 Lakh on record. Court records list 5 cases involving the company, including 1 filed by the company and 4 filed against it; 2 cases are pending.
Spica Laboratories Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-30-0002353). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website spicalab.com.
Company details
CIN U24230TG2005PTC045438
Registration Number 045438
Incorporation Date 22 February 2005
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-30-0002353
CIN history
Spica Laboratories has one previous CIN (Corporate Identification Number): U24230AP2005PTC045438. The current CIN is U24230TG2005PTC045438, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TG2005PTC045438 | Current |
| U24230AP2005PTC045438 | Previous |
Recognitions & Rankings of Spica Laboratories
Contact details
Spica Laboratories Private Limited's registered office is in Hyderabad, Telangana. Its website is spicalab.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressKrishe Sapphire 6th Floor 6B Survey No.88 Madhapur Village Serilingampalli Mandal, Hyderabad, Telangana, India – 500081
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Spica Laboratories Private Limited, buy the company report.
Comprehensive company report
Spica Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Spica Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Spica Laboratories Private Limited, buy the company report.
Financials of Spica Laboratories Private Limited
FY 2024 filings availableSpica Laboratories Private Limited reported revenue of ₹50.21 Cr (down 4% YoY) for FY 2025.
Revenue · FY 2025
₹50.21 Cr ▼ 4%
Net profit · FY 2025
₹3.66 Cr margin 7.3%
EBITDA · FY 2025
₹6.92 Cr margin 13.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 4%
3 years · compounded
▲ 1%
5 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▲ 30%
3 years · compounded
▲ 1%
5 years · compounded
▲ 21%
Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 15%. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.92 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.66 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.8% | ||||
| Net Profit Margin | 7.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Spica Laboratories Private Limited, buy the company report.
Board of directors of Spica Laboratories Private Limited
Spica Laboratories has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nikhil Thota | Managing Director | 01 Dec 2025 | 0 Years 11 Months | Current |
| Giridhar Thota Also directs: Sahasra Laboratories Private Limited, Medha Dyechem Pvt Ltd, Syngen Laboratories Private Limited and 2 more | Director | 08 Oct 2009 | 17 Years 0 Months | Current |
| Rahul Thota | Additional Director | 01 Dec 2025 | 0 Years 11 Months | Current |
| Shobha Thota Also directs: Sahasra Laboratories Private Limited, Medha Dyechem Pvt Ltd, Syngen Laboratories Private Limited and 2 more | Director | 08 Oct 2009 | 17 Years 0 Months | Current |
Peer comparison
Spica Laboratories Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pioneer Agro Industries Sanvin Laboratories Private Limited | ₹50.76 Cr (FY 2025) | 6.0% | Mumbai, Maharashtra, India | |||
| Gujarat Terce Laboratories Limited | ₹50.5 Cr (FY 2025) | 5.0% | Gandhinagar, Gujarat, India | |||
| Ultratech India Limited | ₹50.24 Cr (FY 2025) | 84.0% | Navi Mumbai, Maharashtra, India | |||
| Spica Laboratories Private Limitedthis company | ₹50.21 Cr (FY 2025) | ₹3.66 Cr | 7.3% | -4.0% | Hyderabad, Telangana, India | |
| Sotac Healthcare Private Limited | ₹49.75 Cr (FY 2025) | 7.0% | Ahmedabad, Gujarat, India | |||
| Riocare India Private Limited | ₹49.75 Cr (FY 2025) | -1.0% | Navi Mumbai, Maharashtra, India | |||
| Medipol Pharmaceutical India Private Limited | ₹49.73 Cr (FY 2025) | 10.0% | Delhi, India |
To see the full peer comparison of Spica Laboratories Private Limited, buy the company report.
Auditor
Spica Laboratories Private Limited is audited by ADDURU REDDY & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ADDURU REDDY & CO | FY 2023 | 027907 |
Shareholding
The shareholding of Spica Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Spica Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹90 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Sep 2005 | 80036655 | Union Bank of India Limited | ₹90 Lakh | Satisfied |
To see the full charge records of Spica Laboratories Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Spica Laboratories Private Limited has 5 court cases on record: 1 filed by Spica Laboratories, 4 filed against it. 2 cases are pending and 3 are disposed.
Total cases
5
Filed by the company
1
Filed against the company
4
Pending
2
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 4 | 2 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TAMIL NADU | Appeal | Filed against the company by United India Insurance Co.Ltd | Disposed |
| High Court, TAMIL NADU | Petition | Filed against the company by United India Insurance Co.Ltd. | Disposed |
| High Court, TELANGANA | Writ petition | Filed by the company against Central Power Distribution Company of Andhra Pradesh Ltd., and 4 others | Disposed |
| High Court, TAMIL NADU | Court case (OSA) | Filed against the company by The Commissioner of Customs Sea Port | Pending |
| High Court, TAMIL NADU | Interim or miscellaneous application | Filed against the company by The Commissioner of Customs Sea Port | Pending |
To see the full case history of Spica Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Spica Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Spica Laboratories has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAICS8206P1ZQ | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Spica Laboratories Private Limited, buy the company report.
Recent activity
Spica Laboratories Private Limited has 12 board changes on record since 2007: 4 appointments and 8 cessations. The latest: Nikhil Thota was appointed as Managing Director on 01 Dec 2025.
Appointed
Nikhil Thota was appointed as Managing Director.
Appointed
Rahul Thota was appointed as Additional Director.
AGM
Spica Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Spica Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge registered on 28 Sep 2005 via Charge ID 80036655 with Union Bank Of India Limited was fully satisfied on 03 Feb 2010.
Ceased
Buchi Reddy Reguri ceased to be Director.
Ceased
Radha Reguri ceased to be Director.
Ceased
Radha Reguri ceased to be Director.
Ceased
Sudhakar Bhandari ceased to be Director.
Appointed
Giridhar Thota was appointed as Director.
Appointed
Shobha Thota was appointed as Director.
Ceased
Nagendra Reddy Marla ceased to be Director.
6 earlier events are in the company report.
Frequently asked questions
Spica Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 February 2005 (21+ years old) and is registered under CIN U24230TG2005PTC045438.
Spica Laboratories has 4 current directors:
- Nikhil Thota - Managing Director
- Giridhar Thota - Director
- Rahul Thota - Additional Director
- Shobha Thota - Director
The latest financial statements of Spica Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Spica Laboratories is 36AAICS8206P1ZQ, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Spica Laboratories is U24230TG2005PTC045438. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spica Laboratories has 5 court cases on record: 1 filed by the company and 4 filed against it. 2 are pending.
Spica Laboratories was incorporated on 22 February 2005, making it 21+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Spica Laboratories by revenue are Pioneer Agro Industries Sanvin Laboratories Private Limited, Gujarat Terce Laboratories Limited, Ultratech India Limited, Sotac Healthcare Private Limited, Riocare India Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nikhil Thota was appointed as Managing Director on 01 Dec 2025. Rahul Thota was appointed as Additional Director on 01 Dec 2025. Buchi Reddy Reguri ceased to be Director on 23 Jan 2010. Spica Laboratories has 12 board changes on record in total.
Yes, Spica Laboratories is registered as a small enterprise under Udyam registration (number: UDYAM-TS-30-0002353).
Spica Laboratories can be reached through the website spicalab.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages